Growth Metrics

Johnson & Johnson (JNJ) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $9.7 billion.

  • Johnson & Johnson's Operating Expenses fell 777.39% to $9.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 billion, marking a year-over-year increase of 99.0%. This contributed to the annual value of $40.3 billion for FY2024, which is 876.07% up from last year.
  • Latest data reveals that Johnson & Johnson reported Operating Expenses of $9.7 billion as of Q3 2025, which was down 777.39% from $9.5 billion recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Operating Expenses registered a high of $11.8 billion during Q4 2024, and its lowest value of $7.0 billion during Q1 2023.
  • Moreover, its 5-year median value for Operating Expenses was $9.5 billion (2025), whereas its average is $9.4 billion.
  • The largest annual percentage gain for Johnson & Johnson's Operating Expenses in the last 5 years was 4805.38% (2023), contrasted with its biggest fall of 1033.79% (2023).
  • Johnson & Johnson's Operating Expenses (Quarter) stood at $9.5 billion in 2021, then decreased by 10.09% to $8.5 billion in 2022, then grew by 21.36% to $10.3 billion in 2023, then grew by 13.99% to $11.8 billion in 2024, then decreased by 18.11% to $9.7 billion in 2025.
  • Its Operating Expenses stands at $9.7 billion for Q3 2025, versus $9.5 billion for Q2 2025 and $8.4 billion for Q1 2025.